Beacontx
Founded 2023 · 96 employees on LinkedIn · 5 known investors
Find your way into Beacontx
136 people in our graph share verified history with the Beacontx team — schools, employers, funds. One of them is your warm intro.
Sam Blackmanunlockedknows Daniel Chung · together at Children's Hospital of Philadelphia (overlapped)
×3knows the team · via Harvard Business School Online
×2knows the team · via The Johns Hopkins University
×3knows the team · via Freenome
knows the team · via Children's Hospital of Philadelphia
×2knows the team · via Indiana University School of Medicine
Beacon Therapeutics develops gene therapies for patients with serious diseases that lack or have limited treatment options, including investigational products like laru-zova for genetic conditions.
Founders & leadership
DC
Daniel ChunginChief Medical OfficerDaniel Chung is Chief Medical Officer at Beacon Therapeutics, which develops gene therapies for serious diseases. He brings clinical and medical leadership experience in biotechnology, with specific expertise in ocular gene therapy, translational research, clinical development, and inherited retinal diseases.
LB
Lance BaldoinChief Executive OfficerLance Baldo is a physician and executive with experience in pharmaceutical lifecycle management, business strategy, and medical affairs. He is CEO of Beacon Therapeutics, a gene therapy company developing treatments for serious diseases with limited treatment options.
AS
Abraham ScariainChief Scientific OfficerAbraham Scaria is Chief Scientific Officer of Beacontx, a gene therapy company developing treatments for serious genetic and autoimmune diseases.
Investors · 5
Frequently asked questions
- What does Beacontx do?
- Beacon Therapeutics develops gene therapies for patients with serious diseases that lack or have limited treatment options, including investigational products like laru-zova for genetic conditions.
- Who are Beacontx's investors?
- Beacontx's investors include Advent Life Sciences, Forbion, Oxford Science Enterprises, Syncona, TCG Crossover.